Alternatives to Statins: Your Options Compared
The main non-statin cholesterol medicines are ezetimibe, bempedoic acid, PCSK9 inhibitors, and inclisiran. They lower LDL by about 18% up to 50 to 60%, and which one fits depends on how far your LDL needs to fall.
- Repathaabout 52 mg/dL
Average result would reach under 70.
- Lipfendraabout 53 to 57 mg/dL
Average result would reach under 70.
- Praluentabout 55 to 70 mg/dL
Average result would reach under 70.
- Lerocholabout 57 mg/dL
Average result would reach under 70.
- Leqvioabout 65 mg/dL
Average result would reach under 70.
- Nexlizetabout 81 mg/dL
Average result stays above 70. A second medicine can close the gap.
- Ezetimibeabout 98 to 104 mg/dL
Average result stays above 70. A second medicine can close the gap.
- Nexletolabout 103 to 108 mg/dL
Average result stays above 70. A second medicine can close the gap.
The dark line marks your goal. Starting LDL: 130 mg/dL.
Rough estimate. Trials report the average drop for one medicine, usually compared with placebo and often in people already on a statin, and your result can differ. Use the LDL you have now, on your current treatment. Your clinician sets your goal. Figures match the guides on this site; see each medicine’s guide for the sources.
What are the alternatives to statins?
Other prescription medicines lower LDL cholesterol through different routes, and several have trials showing fewer heart attacks and strokes. Some people do well on a different statin or a lower dose. Others need a non-statin: ezetimibe, bempedoic acid (Nexletol), a PCSK9 inhibitor, or inclisiran (Leqvio).
Supplements and lifestyle changes help some people, but they rarely close a large gap alone. First, find out whether the statin caused the symptoms.
Am I really statin intolerant?
Often the statin turns out to be innocent. In SAMSON (60 UK patients), about 90% of the symptom burden people felt on the statin also showed up on a dummy pill. StatinWISE (200 patients) found no overall difference in muscle symptom scores between atorvastatin 20 mg and placebo, and two thirds of those who finished chose to restart a statin.
The National Lipid Association defines intolerance as symptoms that improve when the statin is reduced or stopped, after trying at least two different statins, including one at the lowest approved daily dose.
If you tried one statin at one dose, you likely still have statin options, such as a different statin, a lower dose, or dosing every other day.
In a Boston study of more than 100,000 patients, about 92% of people restarted on a statin after a suspected side effect still took one a year later.
Severe muscle pain with dark, cola-colored urine or real weakness needs prompt medical attention.
How much does each non-statin option lower LDL?
These are average trial results. They don't add up in a simple way, and combinations are common.
- Ezetimibe (daily generic pill): about 18% alone. Adding it to a statin reduced cardiovascular events in IMPROVE-IT (18,144 people).
- Bempedoic acid (daily pill): about 21% more than placebo. In CLEAR Outcomes (nearly 14,000 statin-intolerant people, about 3.4 years), major cardiovascular events fell 13%. Gout (3.1% vs 2.1%) and gallstones (2.2% vs 1.2%) were somewhat more common.
- Repatha or Praluent (injection every 2 to 4 weeks): about 50 to 60%. Evolocumab lowered LDL 59% in FOURIER and reduced cardiovascular events.
- Lipfendra (daily pill) and Lerochol (monthly self-injection): about 56% versus placebo in their main trials. Neither has an outcomes trial reported yet.
- Leqvio (inclisiran, clinic injection at the start, 3 months, then every 6 months): about 50%. Its outcomes trials haven't reported as of October 2026.
Do natural alternatives to statins work?
They lower LDL modestly at best, and none has been shown to prevent heart attacks the way prescription options have.
Red yeast rice contains monacolin K, which is chemically identical to lovastatin. When researchers tested 28 US brands, none listed the monacolin K amount, two had none, and the rest varied more than 60-fold. It can cause the same side effects as a statin.
Plant sterols and stanols (0.6 to 3.3 grams a day) lowered LDL by about 6 to 12% in a meta-analysis of 124 studies. Oats, beans, barley and psyllium lower LDL modestly. Bergamot and berberine have limited trial evidence.
Tell your care team about every supplement, since some interact with prescriptions.
Can I lower cholesterol without statins using lifestyle?
Lifestyle lowers LDL for most people, though it varies a lot from person to person and rarely closes a large gap alone. Swap saturated fat for unsaturated fats like olive oil, nuts and fish. Eat more soluble fiber and plant foods. Lose weight if you need to, move most days, and keep blood pressure and blood sugar in range.
If your high cholesterol is largely genetic, diet often moves the number less than you'd hope, despite real effort.
What should I do if I already stopped my statin?
Your LDL drifts back toward where it was before treatment, and the protection goes with it. Get fresh labs, write down which statin, what dose, what symptoms and how long, and choose a path with a clinician: a structured retry, a non-statin, or both.
Trials in this guide
Each links to a plain summary with a quote from the PubMed abstract.
- IMPROVE-IT (2015) · Ezetimibe + simvastatin · 18,144 peopleBenefit
- FOURIER (2017) · Evolocumab · 27,564 peopleBenefit
- SAMSON (2021) · Atorvastatin · 60 peopleSymptoms largely nocebo
- StatinWISE (2021) · Atorvastatin · 200 peopleNo excess harm vs placebo
- CLEAR Outcomes (2023) · Bempedoic acid · 13,970 peopleBenefit
Common questions
▸What are the non-statin cholesterol medicines?
Ezetimibe, bempedoic acid (Nexletol), PCSK9 inhibitors (Repatha, Praluent, monthly Lerochol, daily pill Lipfendra), and inclisiran (Leqvio). They lower LDL by roughly 18% (ezetimibe) up to 50 to 60% (PCSK9 inhibitors), and several can be combined.
▸What is the best alternative to statins?
It varies by person. Ezetimibe and bempedoic acid are daily pills that lower LDL by roughly 18 to 21% each, and both have trials showing fewer cardiovascular events. PCSK9 inhibitors lower LDL by about 50 to 60%. The right fit depends on how far your LDL needs to fall and your other conditions.
▸Is red yeast rice as good as a statin?
Red yeast rice can lower LDL because it contains monacolin K, identical to lovastatin. Supplements aren't regulated as drugs, and US products varied more than 60-fold in monacolin K, with some containing none. It can cause the same side effects as a statin.
▸What happens if I stop taking statins?
Your LDL drifts back toward its pretreatment level, and the protection against heart attack and stroke goes with it. If you already stopped, make a plan soon with your clinician.
▸How do I know if I'm truly statin intolerant?
The National Lipid Association requires that symptoms improve when the statin is reduced or stopped, and that at least two statins were tried, including one at the lowest approved daily dose. A structured retry is usually the most reliable way to find out.
▸What are the side effects of non-statin cholesterol drugs?
Generally mild. In IMPROVE-IT, ezetimibe's muscle, gallbladder and liver side effects were similar to placebo. Bempedoic acid slightly raised gout (3.1% vs 2.1%) and gallstones (2.2% vs 1.2%) in CLEAR Outcomes. Injectable PCSK9 inhibitors most often cause injection-site reactions and cold-like symptoms.
Read next
- Statin Side Effects: What's Real and What To DoAbout 1 in 10 people blame a statin for muscle aches, but blinded trials link far fewer to the drug. See which side effects are real.Read
- Rosuvastatin vs Atorvastatin: Which To Take?Rosuvastatin (Crestor) vs atorvastatin (Lipitor): LDL lowering, heart attack results, side effects, kidney dosing and interactions, in plain words.Read
- Statin Gene Testing: SLCO1B1 ExplainedWhat SLCO1B1, ABCG2 and CYP2C9 results mean for statin muscle side effects, what CPIC advises, who benefits from testing and where the evidence thins.Read
See it on lipid.site
Sources
- Ezetimibe FDA label, DailyMed, NIH
- Red yeast rice, NIH NCCIH
- Statin treatment and muscle symptoms: randomised placebo controlled n-of-1 trials (StatinWISE), BMJ, 2021
- NLA scientific statement on statin intolerance, Journal of Clinical Lipidology, 2022
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes (IMPROVE-IT), New England Journal of Medicine, 2015
- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients (CLEAR Outcomes), New England Journal of Medicine, 2023
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER), New England Journal of Medicine, 2017
Not medical advice. General education from published trials and drug labels, last updated October 2026. lipid.site is not a healthcare provider and cannot tell you what to take or change. Talk to your clinician before starting or stopping any treatment. If you have chest pain or other signs of a heart attack or stroke, call 911.